Stock Price
1,513.00
Daily Change
11.35 0.76%
Monthly
10.62%
Yearly
26.96%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR9.1B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Cipla INR 5.55B 1.21B Mar/2026
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Dr.Reddys Laboratories INR 2.21B 9.89B Mar/2026
Hindustan Unilever INR 29.92B 36.15B Mar/2026
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
UPL INR 10.61B 6.65B Mar/2026